Pamisel, Top Search Ranking... Stock Price Up 3.56%
As of 9:30 AM on the 29th, Pamicell is trading at 23,300 KRW, up 3.56% from the previous day. This marks a 22.63% increase compared to April 29. Pamicell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.
Over the past five days, individual investors have net sold 41,071 shares, while foreigners and institutions have net bought 82,205 shares and 72,425 shares, respectively.
On May 26, Pamicell became a market topic with the news "Remdesivir special import possible... bullish."
※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
![About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]](https://cwcontent.asiae.co.kr/asiaresize/93/2026051416263163580_1778743590.jpg)
About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- "Envious of Korean Daily Life"...Foreign Tourists Line Up in Central Myeongdong from Early Morning [Reportage]
- Woman in Her 50s Found Dead 28 Days After Going Missing on Bukhansan Mountain
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
